After 8 months of stringent market testing the CHA has finally approved the InnovativeCBD line of wellness products for distribution as our first CHA Approved product. CHA Approved products are those which have undergone at least 6 months of quality assurance testing, research, and data. Depending on the product, the CHA will set up custom market analysis involving case study and total customer satisfaction. The CHA will not approve any product or service that has not passed our quality assurance with flying colors.
The advantage of CHA Approved products are they have been tested and approved for distribution by our sister company Agricultural Evolution International (AEI). While not all CHA Approved products will be put into the portfolio by AEI, the vetting process and ultimately the CHA's rubber stamp of approval will give product manufacturer's a seal of confidence that their product has been tested, vetted, and approved with real people versus simply using the general public and their disposable income as a guinea pig.
In addition to the landmark deal executed by the CHA, AEI, and Innovative Extractions you may have heard that New York has officially named it's first five license holders. Surprisingly Fiorello Pharmaceuticals was left out, Terra Tech left out, Compassionate Care NY left out. So many of the highly publicized applicants were left out in the cold while NY made some very solid choices in our opinion. We had predicted that at least (2) of the five applicants would have deep connections to the state which proved to be true as Etain and Bloomfield won and both have deep roots into the inner workings of New York State. Perhaps the most concerning was our inability to find any minority owned businesses or executives in the teams, but there were many women involved in the company executive teams we found. With any luck next round we will some more diversity.
This month's August CHA Newsletter discusses more about the licensing, our events, and news. Check it out!